Cargando…
Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?
Introduction: Benzodiazepines (BZDs) are used in the management of anxiety and sleep disorders; however, chronic use is associated with tolerance and dependence. During withdrawal, symptoms of anxiety are often severe and problematic for patients and may lead to relapse or maintenance on low doses o...
Autores principales: | Gallo, Alexander, MacDonald, Tim, Bennett, Kellie, Basso-Hulse, Gioiamia, Hulse, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573680/ https://www.ncbi.nlm.nih.gov/pubmed/36233814 http://dx.doi.org/10.3390/jcm11195948 |
Ejemplares similares
-
Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series
por: Gallo, Alexander T., et al.
Publicado: (2022) -
Addiction of High Dose of Benzodiazepine: Verona Detox Approach With Flumazenil
por: Casari, Rebecca, et al.
Publicado: (2022) -
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification
por: Benini, Anna, et al.
Publicado: (2021) -
The role of flumazenil in generalised anxiety disorder: a pilot
naturalistic open-label study with a focus on treatment
resistance
por: Gallo, Alexander T, et al.
Publicado: (2023) -
High-Dose Benzodiazepines Positively Modulate GABA(A) Receptors via a Flumazenil-Insensitive Mechanism
por: Wang, Na, et al.
Publicado: (2021)